The Weekly Take from CBRE cover image

We Go Together: Johnson & Johnson on talent clusters, biotech innovation and venture capital flows in Life Sciences

The Weekly Take from CBRE

00:00

Drug design trends, cost of drug development, and balancing safety with earlier approvals

This chapter explores the evolution of drug design, including the use of technology and AI. It also delves into the cost of drug development, the lessons learned from COVID vaccine approval, the significance of clinical trials, and the challenge of balancing safety with faster approvals.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app